APO Research
Talk to an analyst

APO RESEARCH · REPORT

C-C Chemokine Receptor Type 4

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global C-C Chemokine Receptor Type 4 Market Analysis and Forecast 2026-2032

19 December 2025197 pages

Choose your research edition.

Industry ResearchC-C Chemokine Receptor Type 4 Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal C-C Chemokine Receptor Type 4 Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal C-C Chemokine Receptor Type 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C-C Chemokine Receptor Type 4 Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal C-C Chemokine Receptor Type 4 Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global C-C Chemokine Receptor Type 4 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for C-C Chemokine Receptor Type 4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for C-C Chemokine Receptor Type 4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for C-C Chemokine Receptor Type 4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for C-C Chemokine Receptor Type 4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of C-C Chemokine Receptor Type 4 include AstraZeneca Plc, Ono Pharmaceutical Co Ltd, Kyowa Hakko Kirin Co Ltd, Globavir Biosciences Inc, FLX Bio Inc, Corion Biotech Srl, ChemoCentryx Inc and Affitech A/S, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for C-C Chemokine Receptor Type 4, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of C-C Chemokine Receptor Type 4, also provides the revenue of main regions and countries. Of the upcoming market potential for C-C Chemokine Receptor Type 4, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the C-C Chemokine Receptor Type 4 revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global C-C Chemokine Receptor Type 4 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for C-C Chemokine Receptor Type 4 revenue, projected growth trends, production technology, application and end-user industry.

C-C Chemokine Receptor Type 4 Segment by Company

AstraZeneca Plc

Ono Pharmaceutical Co Ltd

Kyowa Hakko Kirin Co Ltd

Globavir Biosciences Inc

FLX Bio Inc

Corion Biotech Srl

ChemoCentryx Inc

Affitech A/S

C-C Chemokine Receptor Type 4 Segment by Type

K-777

GBV-3019

E-0001163

CCX-6239

Others

C-C Chemokine Receptor Type 4 Segment by Application

Central Nervous System

Immunology

Mycosis Fungoides

Others

C-C Chemokine Receptor Type 4 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C-C Chemokine Receptor Type 4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C-C Chemokine Receptor Type 4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C-C Chemokine Receptor Type 4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of C-C Chemokine Receptor Type 4 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of C-C Chemokine Receptor Type 4 company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, C-C Chemokine Receptor Type 4 revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global C-C Chemokine Receptor Type 4 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. K-777 Major Player Table 3. GBV-3019 Major Player Table 4. E-0001163 Major Player Table 5. CCX-6239 Major Player Table 6. Others Major Player Table 7. Global C-C Chemokine Receptor Type 4 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Central Nervous System Major Player Table 9. Immunology Major Player Table 10. Mycosis Fungoides Major Player Table 11. Others Major Player Table 12. C-C Chemokine Receptor Type 4 Industry Trends Table 13. C-C Chemokine Receptor Type 4 Industry Drivers Table 14. C-C Chemokine Receptor Type 4 Industry Opportunities and Challenges Table 15. C-C Chemokine Receptor Type 4 Industry Restraints Table 16. Global C-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global C-C Chemokine Receptor Type 4 Market Size by Region (2021-2026) & (US$ Million) Table 18. Global C-C Chemokine Receptor Type 4 Market Share by Region (2021-2026) Table 19. Global C-C Chemokine Receptor Type 4 Market Size by Region (2027-2032) & (US$ Million) Table 20. Global C-C Chemokine Receptor Type 4 Market Share by Region (2027-2032) Table 21. Global C-C Chemokine Receptor Type 4 Revenue by Players (US$ Million) & (2021-2026) Table 22. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Players (2021-2026) Table 23. Global C-C Chemokine Receptor Type 4 Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global C-C Chemokine Receptor Type 4 Key Players Headquarters & Area Served Table 25. Global C-C Chemokine Receptor Type 4 Players, Product Type & Application Table 26. Global C-C Chemokine Receptor Type 4 Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global C-C Chemokine Receptor Type 4 by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global C-C Chemokine Receptor Type 4 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global C-C Chemokine Receptor Type 4 Revenue by Type (2021-2026) & (US$ Million) Table 31. Global C-C Chemokine Receptor Type 4 Revenue by Type (2027-2032) & (US$ Million) Table 32. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Type (2021-2026) Table 33. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Type (2027-2032) Table 34. Global C-C Chemokine Receptor Type 4 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global C-C Chemokine Receptor Type 4 Revenue by Application (2021-2026) & (US$ Million) Table 36. Global C-C Chemokine Receptor Type 4 Revenue by Application (2027-2032) & (US$ Million) Table 37. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Application (2021-2026) Table 38. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Application (2027-2032) Table 39. AstraZeneca Plc Company Information Table 40. AstraZeneca Plc Business Overview Table 41. AstraZeneca Plc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. AstraZeneca Plc C-C Chemokine Receptor Type 4 Product Portfolio Table 43. AstraZeneca Plc Recent Development Table 44. Ono Pharmaceutical Co Ltd Company Information Table 45. Ono Pharmaceutical Co Ltd Business Overview Table 46. Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Product Portfolio Table 48. Ono Pharmaceutical Co Ltd Recent Development Table 49. Kyowa Hakko Kirin Co Ltd Company Information Table 50. Kyowa Hakko Kirin Co Ltd Business Overview Table 51. Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Product Portfolio Table 53. Kyowa Hakko Kirin Co Ltd Recent Development Table 54. Globavir Biosciences Inc Company Information Table 55. Globavir Biosciences Inc Business Overview Table 56. Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Product Portfolio Table 58. Globavir Biosciences Inc Recent Development Table 59. FLX Bio Inc Company Information Table 60. FLX Bio Inc Business Overview Table 61. FLX Bio Inc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. FLX Bio Inc C-C Chemokine Receptor Type 4 Product Portfolio Table 63. FLX Bio Inc Recent Development Table 64. Corion Biotech Srl Company Information Table 65. Corion Biotech Srl Business Overview Table 66. Corion Biotech Srl C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Corion Biotech Srl C-C Chemokine Receptor Type 4 Product Portfolio Table 68. Corion Biotech Srl Recent Development Table 69. ChemoCentryx Inc Company Information Table 70. ChemoCentryx Inc Business Overview Table 71. ChemoCentryx Inc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. ChemoCentryx Inc C-C Chemokine Receptor Type 4 Product Portfolio Table 73. ChemoCentryx Inc Recent Development Table 74. Affitech A/S Company Information Table 75. Affitech A/S Business Overview Table 76. Affitech A/S C-C Chemokine Receptor Type 4 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Affitech A/S C-C Chemokine Receptor Type 4 Product Portfolio Table 78. Affitech A/S Recent Development Table 79. North America C-C Chemokine Receptor Type 4 Revenue by Type (2021-2026) & (US$ Million) Table 80. North America C-C Chemokine Receptor Type 4 Revenue by Type (2027-2032) & (US$ Million) Table 81. North America C-C Chemokine Receptor Type 4 Revenue by Application (2021-2026) & (US$ Million) Table 82. North America C-C Chemokine Receptor Type 4 Revenue by Application (2027-2032) & (US$ Million) Table 83. North America C-C Chemokine Receptor Type 4 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. North America C-C Chemokine Receptor Type 4 Revenue by Country (2021-2026) & (US$ Million) Table 85. North America C-C Chemokine Receptor Type 4 Revenue by Country (US$ Million) & (2027-2032) Table 86. Europe C-C Chemokine Receptor Type 4 Revenue by Type (2021-2026) & (US$ Million) Table 87. Europe C-C Chemokine Receptor Type 4 Revenue by Type (2027-2032) & (US$ Million) Table 88. Europe C-C Chemokine Receptor Type 4 Revenue by Application (2021-2026) & (US$ Million) Table 89. Europe C-C Chemokine Receptor Type 4 Revenue by Application (2027-2032) & (US$ Million) Table 90. Europe C-C Chemokine Receptor Type 4 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. Europe C-C Chemokine Receptor Type 4 Revenue by Country (2021-2026) & (US$ Million) Table 92. Europe C-C Chemokine Receptor Type 4 Revenue by Country (US$ Million) & (2027-2032) Table 93. China C-C Chemokine Receptor Type 4 Revenue by Type (2021-2026) & (US$ Million) Table 94. China C-C Chemokine Receptor Type 4 Revenue by Type (2027-2032) & (US$ Million) Table 95. China C-C Chemokine Receptor Type 4 Revenue by Application (2021-2026) & (US$ Million) Table 96. China C-C Chemokine Receptor Type 4 Revenue by Application (2027-2032) & (US$ Million) Table 97. Asia C-C Chemokine Receptor Type 4 Revenue by Type (2021-2026) & (US$ Million) Table 98. Asia C-C Chemokine Receptor Type 4 Revenue by Type (2027-2032) & (US$ Million) Table 99. Asia C-C Chemokine Receptor Type 4 Revenue by Application (2021-2026) & (US$ Million) Table 100. Asia C-C Chemokine Receptor Type 4 Revenue by Application (2027-2032) & (US$ Million) Table 101. Asia C-C Chemokine Receptor Type 4 Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Asia C-C Chemokine Receptor Type 4 Revenue by Region (US$ Million) & (2021-2026) Table 103. Asia C-C Chemokine Receptor Type 4 Revenue by Region (US$ Million) & (2027-2032) Table 104. SAMEA C-C Chemokine Receptor Type 4 Revenue by Type (2021-2026) & (US$ Million) Table 105. SAMEA C-C Chemokine Receptor Type 4 Revenue by Type (2027-2032) & (US$ Million) Table 106. SAMEA C-C Chemokine Receptor Type 4 Revenue by Application (2021-2026) & (US$ Million) Table 107. SAMEA C-C Chemokine Receptor Type 4 Revenue by Application (2027-2032) & (US$ Million) Table 108. SAMEA C-C Chemokine Receptor Type 4 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. SAMEA C-C Chemokine Receptor Type 4 Revenue by Country (2021-2026) & (US$ Million) Table 110. SAMEA C-C Chemokine Receptor Type 4 Revenue by Country (US$ Million) & (2027-2032) Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. C-C Chemokine Receptor Type 4 Image Figure 2. Global C-C Chemokine Receptor Type 4 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global C-C Chemokine Receptor Type 4 Market Size Share 2021 VS 2025 VS 2032 Figure 4. K-777 Image Figure 5. GBV-3019 Image Figure 6. E-0001163 Image Figure 7. CCX-6239 Image Figure 8. Others Image Figure 9. Global C-C Chemokine Receptor Type 4 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global C-C Chemokine Receptor Type 4 Market Size Share 2021 VS 2025 VS 2032 Figure 11. Central Nervous System Image Figure 12. Immunology Image Figure 13. Mycosis Fungoides Image Figure 14. Others Image Figure 15. Global C-C Chemokine Receptor Type 4 Market Size (US$ Million) & (2021-2032) Figure 16. Global C-C Chemokine Receptor Type 4 Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global C-C Chemokine Receptor Type 4 Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global C-C Chemokine Receptor Type 4 Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global C-C Chemokine Receptor Type 4 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global C-C Chemokine Receptor Type 4 Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Type (2021-2032) Figure 23. Global C-C Chemokine Receptor Type 4 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Application (2021-2032) Figure 26. North America C-C Chemokine Receptor Type 4 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America C-C Chemokine Receptor Type 4 Revenue Share by Type (2021-2032) Figure 28. North America C-C Chemokine Receptor Type 4 Revenue Share by Application (2021-2032) Figure 29. North America C-C Chemokine Receptor Type 4 Revenue Share by Country (2021-2032) Figure 30. United States C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe C-C Chemokine Receptor Type 4 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe C-C Chemokine Receptor Type 4 Revenue Share by Type (2021-2032) Figure 35. Europe C-C Chemokine Receptor Type 4 Revenue Share by Application (2021-2032) Figure 36. Europe C-C Chemokine Receptor Type 4 Revenue Share by Country (2021-2032) Figure 37. Germany C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China C-C Chemokine Receptor Type 4 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China C-C Chemokine Receptor Type 4 Revenue Share by Type (2021-2032) Figure 47. China C-C Chemokine Receptor Type 4 Revenue Share by Application (2021-2032) Figure 48. Asia C-C Chemokine Receptor Type 4 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia C-C Chemokine Receptor Type 4 Revenue Share by Type (2021-2032) Figure 50. Asia C-C Chemokine Receptor Type 4 Revenue Share by Application (2021-2032) Figure 51. Asia C-C Chemokine Receptor Type 4 Revenue Share by Region (2021-2032) Figure 52. Japan C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA C-C Chemokine Receptor Type 4 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA C-C Chemokine Receptor Type 4 Revenue Share by Type (2021-2032) Figure 60. SAMEA C-C Chemokine Receptor Type 4 Revenue Share by Application (2021-2032) Figure 61. SAMEA C-C Chemokine Receptor Type 4 Revenue Share by Country (2021-2032) Figure 62. Brazil C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt C-C Chemokine Receptor Type 4 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • K-777
  • GBV-3019
  • E-0001163
  • CCX-6239
  • Others
Applications
  • Central Nervous System
  • Immunology
  • Mycosis Fungoides
  • Others
Companies covered
  • AstraZeneca Plc
  • Ono Pharmaceutical Co Ltd
  • Kyowa Hakko Kirin Co Ltd
  • Globavir Biosciences Inc
  • FLX Bio Inc
  • Corion Biotech Srl
  • ChemoCentryx Inc
  • Affitech A/S

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 C-C Chemokine Receptor Type 4 Market by Type
  3. 1.2.1 Global C-C Chemokine Receptor Type 4 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 K-777
  5. 1.2.3 GBV-3019
  6. 1.2.4 E-0001163
  7. 1.2.5 CCX-6239
  8. 1.2.6 Others
  9. 1.3 C-C Chemokine Receptor Type 4 Market by Application
  10. 1.3.1 Global C-C Chemokine Receptor Type 4 Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Central Nervous System
  12. 1.3.3 Immunology
  13. 1.3.4 Mycosis Fungoides
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 C-C Chemokine Receptor Type 4 Market Dynamics
  1. 2.1 C-C Chemokine Receptor Type 4 Industry Trends
  2. 2.2 C-C Chemokine Receptor Type 4 Industry Drivers
  3. 2.3 C-C Chemokine Receptor Type 4 Industry Opportunities and Challenges
  4. 2.4 C-C Chemokine Receptor Type 4 Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global C-C Chemokine Receptor Type 4 Market Perspective (2021-2032)
  2. 3.2 Global C-C Chemokine Receptor Type 4 Growth Trends by Region
  3. 3.2.1 Global C-C Chemokine Receptor Type 4 Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global C-C Chemokine Receptor Type 4 Market Size by Region (2021-2026)
  5. 3.2.3 Global C-C Chemokine Receptor Type 4 Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global C-C Chemokine Receptor Type 4 Revenue by Players
  2. 4.1.1 Global C-C Chemokine Receptor Type 4 Revenue by Players (2021-2026)
  3. 4.1.2 Global C-C Chemokine Receptor Type 4 Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global C-C Chemokine Receptor Type 4 Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global C-C Chemokine Receptor Type 4 Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global C-C Chemokine Receptor Type 4 Key Players Headquarters & Area Served
  7. 4.4 Global C-C Chemokine Receptor Type 4 Players, Product Type & Application
  8. 4.5 Global C-C Chemokine Receptor Type 4 Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global C-C Chemokine Receptor Type 4 Market CR5 and HHI
  11. 4.6.3 2025 C-C Chemokine Receptor Type 4 Tier 1, Tier 2, and Tier 3
5 C-C Chemokine Receptor Type 4 Market Size by Type
  1. 5.1 Global C-C Chemokine Receptor Type 4 Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global C-C Chemokine Receptor Type 4 Revenue by Type (2021-2032)
  3. 5.3 Global C-C Chemokine Receptor Type 4 Revenue Market Share by Type (2021-2032)
6 C-C Chemokine Receptor Type 4 Market Size by Application
  1. 6.1 Global C-C Chemokine Receptor Type 4 Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global C-C Chemokine Receptor Type 4 Revenue by Application (2021-2032)
  3. 6.3 Global C-C Chemokine Receptor Type 4 Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AstraZeneca Plc
  2. 7.1.1 AstraZeneca Plc Company Information
  3. 7.1.2 AstraZeneca Plc Business Overview
  4. 7.1.3 AstraZeneca Plc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AstraZeneca Plc C-C Chemokine Receptor Type 4 Product Portfolio
  6. 7.1.5 AstraZeneca Plc Recent Developments
  7. 7.2 Ono Pharmaceutical Co Ltd
  8. 7.2.1 Ono Pharmaceutical Co Ltd Company Information
  9. 7.2.2 Ono Pharmaceutical Co Ltd Business Overview
  10. 7.2.3 Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Product Portfolio
  12. 7.2.5 Ono Pharmaceutical Co Ltd Recent Developments
  13. 7.3 Kyowa Hakko Kirin Co Ltd
  14. 7.3.1 Kyowa Hakko Kirin Co Ltd Company Information
  15. 7.3.2 Kyowa Hakko Kirin Co Ltd Business Overview
  16. 7.3.3 Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Product Portfolio
  18. 7.3.5 Kyowa Hakko Kirin Co Ltd Recent Developments
  19. 7.4 Globavir Biosciences Inc
  20. 7.4.1 Globavir Biosciences Inc Company Information
  21. 7.4.2 Globavir Biosciences Inc Business Overview
  22. 7.4.3 Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Product Portfolio
  24. 7.4.5 Globavir Biosciences Inc Recent Developments
  25. 7.5 FLX Bio Inc
  26. 7.5.1 FLX Bio Inc Company Information
  27. 7.5.2 FLX Bio Inc Business Overview
  28. 7.5.3 FLX Bio Inc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (2021-2026)
  29. 7.5.4 FLX Bio Inc C-C Chemokine Receptor Type 4 Product Portfolio
  30. 7.5.5 FLX Bio Inc Recent Developments
  31. 7.6 Corion Biotech Srl
  32. 7.6.1 Corion Biotech Srl Company Information
  33. 7.6.2 Corion Biotech Srl Business Overview
  34. 7.6.3 Corion Biotech Srl C-C Chemokine Receptor Type 4 Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Corion Biotech Srl C-C Chemokine Receptor Type 4 Product Portfolio
  36. 7.6.5 Corion Biotech Srl Recent Developments
  37. 7.7 ChemoCentryx Inc
  38. 7.7.1 ChemoCentryx Inc Company Information
  39. 7.7.2 ChemoCentryx Inc Business Overview
  40. 7.7.3 ChemoCentryx Inc C-C Chemokine Receptor Type 4 Revenue and Gross Margin (2021-2026)
  41. 7.7.4 ChemoCentryx Inc C-C Chemokine Receptor Type 4 Product Portfolio
  42. 7.7.5 ChemoCentryx Inc Recent Developments
  43. 7.8 Affitech A/S
  44. 7.8.1 Affitech A/S Company Information
  45. 7.8.2 Affitech A/S Business Overview
  46. 7.8.3 Affitech A/S C-C Chemokine Receptor Type 4 Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Affitech A/S C-C Chemokine Receptor Type 4 Product Portfolio
  48. 7.8.5 Affitech A/S Recent Developments
8 North America
  1. 8.1 North America C-C Chemokine Receptor Type 4 Revenue (2021-2032)
  2. 8.2 North America C-C Chemokine Receptor Type 4 Revenue by Type (2021-2032)
  3. 8.2.1 North America C-C Chemokine Receptor Type 4 Revenue by Type (2021-2026)
  4. 8.2.2 North America C-C Chemokine Receptor Type 4 Revenue by Type (2027-2032)
  5. 8.3 North America C-C Chemokine Receptor Type 4 Revenue Share by Type (2021-2032)
  6. 8.4 North America C-C Chemokine Receptor Type 4 Revenue by Application (2021-2032)
  7. 8.4.1 North America C-C Chemokine Receptor Type 4 Revenue by Application (2021-2026)
  8. 8.4.2 North America C-C Chemokine Receptor Type 4 Revenue by Application (2027-2032)
  9. 8.5 North America C-C Chemokine Receptor Type 4 Revenue Share by Application (2021-2032)
  10. 8.6 North America C-C Chemokine Receptor Type 4 Revenue by Country
  11. 8.6.1 North America C-C Chemokine Receptor Type 4 Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America C-C Chemokine Receptor Type 4 Revenue by Country (2021-2026)
  13. 8.6.3 North America C-C Chemokine Receptor Type 4 Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe C-C Chemokine Receptor Type 4 Revenue (2021-2032)
  2. 9.2 Europe C-C Chemokine Receptor Type 4 Revenue by Type (2021-2032)
  3. 9.2.1 Europe C-C Chemokine Receptor Type 4 Revenue by Type (2021-2026)
  4. 9.2.2 Europe C-C Chemokine Receptor Type 4 Revenue by Type (2027-2032)
  5. 9.3 Europe C-C Chemokine Receptor Type 4 Revenue Share by Type (2021-2032)
  6. 9.4 Europe C-C Chemokine Receptor Type 4 Revenue by Application (2021-2032)
  7. 9.4.1 Europe C-C Chemokine Receptor Type 4 Revenue by Application (2021-2026)
  8. 9.4.2 Europe C-C Chemokine Receptor Type 4 Revenue by Application (2027-2032)
  9. 9.5 Europe C-C Chemokine Receptor Type 4 Revenue Share by Application (2021-2032)
  10. 9.6 Europe C-C Chemokine Receptor Type 4 Revenue by Country
  11. 9.6.1 Europe C-C Chemokine Receptor Type 4 Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe C-C Chemokine Receptor Type 4 Revenue by Country (2021-2026)
  13. 9.6.3 Europe C-C Chemokine Receptor Type 4 Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China C-C Chemokine Receptor Type 4 Revenue (2021-2032)
  2. 10.2 China C-C Chemokine Receptor Type 4 Revenue by Type (2021-2032)
  3. 10.2.1 China C-C Chemokine Receptor Type 4 Revenue by Type (2021-2026)
  4. 10.2.2 China C-C Chemokine Receptor Type 4 Revenue by Type (2027-2032)
  5. 10.3 China C-C Chemokine Receptor Type 4 Revenue Share by Type (2021-2032)
  6. 10.4 China C-C Chemokine Receptor Type 4 Revenue by Application (2021-2032)
  7. 10.4.1 China C-C Chemokine Receptor Type 4 Revenue by Application (2021-2026)
  8. 10.4.2 China C-C Chemokine Receptor Type 4 Revenue by Application (2027-2032)
  9. 10.5 China C-C Chemokine Receptor Type 4 Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia C-C Chemokine Receptor Type 4 Revenue (2021-2032)
  2. 11.2 Asia C-C Chemokine Receptor Type 4 Revenue by Type (2021-2032)
  3. 11.2.1 Asia C-C Chemokine Receptor Type 4 Revenue by Type (2021-2026)
  4. 11.2.2 Asia C-C Chemokine Receptor Type 4 Revenue by Type (2027-2032)
  5. 11.3 Asia C-C Chemokine Receptor Type 4 Revenue Share by Type (2021-2032)
  6. 11.4 Asia C-C Chemokine Receptor Type 4 Revenue by Application (2021-2032)
  7. 11.4.1 Asia C-C Chemokine Receptor Type 4 Revenue by Application (2021-2026)
  8. 11.4.2 Asia C-C Chemokine Receptor Type 4 Revenue by Application (2027-2032)
  9. 11.5 Asia C-C Chemokine Receptor Type 4 Revenue Share by Application (2021-2032)
  10. 11.6 Asia C-C Chemokine Receptor Type 4 Revenue by Country
  11. 11.6.1 Asia C-C Chemokine Receptor Type 4 Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia C-C Chemokine Receptor Type 4 Revenue by Country (2021-2026)
  13. 11.6.3 Asia C-C Chemokine Receptor Type 4 Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA C-C Chemokine Receptor Type 4 Revenue (2021-2032)
  2. 12.2 SAMEA C-C Chemokine Receptor Type 4 Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA C-C Chemokine Receptor Type 4 Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA C-C Chemokine Receptor Type 4 Revenue by Type (2027-2032)
  5. 12.3 SAMEA C-C Chemokine Receptor Type 4 Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA C-C Chemokine Receptor Type 4 Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA C-C Chemokine Receptor Type 4 Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA C-C Chemokine Receptor Type 4 Revenue by Application (2027-2032)
  9. 12.5 SAMEA C-C Chemokine Receptor Type 4 Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA C-C Chemokine Receptor Type 4 Revenue by Country
  11. 12.6.1 SAMEA C-C Chemokine Receptor Type 4 Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA C-C Chemokine Receptor Type 4 Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA C-C Chemokine Receptor Type 4 Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst